Newsletter

000100 - Yuhan Corporation

000100 Summary
Biopharma
Stock Price & Overview
₩81,400 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩81,400  ≈ US$58  ·  Market cap ₩6.0tn (≈ $4.3bn)
What kstock news is. Short items on what actually happened — a filing, an order, a buyback, a result — written from the Korean filing or the Korean press for people who cannot read either. Each one puts the event against a figure from this company's own statements. No view, no rating; that is what analysis is for.

000100 News

All kstock news »
ks

Yuhan signs $95m API supply deal with unnamed global drugmaker

Yuhan Corporation (000100) said in a filing Tuesday that it signed a contract to supply active pharmaceutical ingredient (API) to a buyer it identifies only as "a global pharmaceutical company," worth KRW 131.07bn (~$95.4m at the day's exchange rate).

kstock NewsSep 1, 6:41 PM
1 item. Written from DART filings and Korean press reports; every item lists its source.

Similar to 000100

SymbolLast Price
326030SK biopharmaceuticals Co., Ltd.₩86,600
+0.2%
128940Hanmi Pharm. Co., Ltd.₩473,500
+2.8%
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.